Revolutionary Breakthrough in Pulmonary Fibrosis Treatment
Surrozen Inc. has recently published a study in “Respiratory Research” that showcases the potential of its Wnt mimetic antibody to effectively treat pulmonary fibrosis. Utilizing an acute bleomycin model, this preclinical research demonstrates the antibody’s ability to decrease inflammation and fibrosis while improving lung function. Understanding Pulmonary Fibrosis and Wnt Pathway’s Role Pulmonary fibrosis is […]
COPD: Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease, or COPD, is a progressive lung disease that makes it difficult to breathe. The main symptoms of COPD are coughing, wheezing, and shortness of breath. Millions of people around the world are living with COPD, and the number of cases is only expected to increase in the years to come. If […]